We just learned something huge about Oxford’s coronavirus vaccine – BGR

• New data published about the Oxford AstraZeneca coronavirus vaccine shows promising efficacy data.
• However, there’s a caveat: It seems that the vaccine was shown to be 90% effective only in a small group that got a half-dose of the vaccine first.
• This may lead regulators in the UK, US, and Europe to come to different conclusions about the vaccine.

AstraZeneca and Oxford had announced the Phase 3 interim data a few days ago for their experimental coronavirus vaccine candidate, revealing that the drug…

Click here to view the original article.